SlideShare a Scribd company logo
1 of 75
Cohort Study
Achyut Raj Pandey
Nepal Health Research Council
1
Concept of cohort
The word cohort is derived from the Latin “cohorts”
meaning an enclosure, company, or crowd.
In Roman times a cohort was a body of 300–600
infantry.
In epidemiological terms the cohort is a group of
people with something in common, usually an
exposure or involvement in a defined population
group.
2
Definition
• Cohort study is a type of analytical study
which is undertaken to obtain additional
evidence to refute or support existence of
association between suspected cause and
diseases.
• Other names of cohort study are Longitudinal
study, Incidence study and forward looking
study
3
Features of cohort studies
• Cohorts are identified prior to appearance of
disease under investigation
• The study groups are observed over a period
of time to determine the frequency of disease
among them
• The study proceeds from cause to effects
4
Indications for cohort study
• There is good evidence of an association between
exposure and disease, from other studies.
• Exposure is rare.
• Attrition of study population can be minimized.
• Sufficient fund is available.
5
Framework of cohort study
6
Design of Cohort Study
Then
(a+b) is called study cohort and (c+d) is called control cohort
7
Consideration during selection of
Cohort
• The cohort must be free from disease under study.
• Insofar as the knowledge permits, both the groups
should be equally susceptible to disease under study.
• Both the groups must be comparable in respect of all
variable which influence the occurrence of disease
• Diagnostic and eligibility criteria of the disease must
be defined beforehand. 8
Types of cohort study
• Prospective study
• Retrospective cohort study
• Ambi-directional cohort study
9
Prospective cohort study
• The common strategy of cohort studies is to start
with a reference population (or a representative
sample thereof), some of whom have certain
characteristics or attributes relevant to the study
(exposed group), with others who do not have those
characteristics (unexposed group).
• Both groups should, at the outset of the study, be
free from the condition under consideration. Both
groups are then observed over a specified period to
find out the risk each group has of developing the
condition(s) of interest.
10
Example of Prospective Cohort Study
Framingham Heart Study Framework
• Initiated in 1948 to study the
relationship of a variety of factors
to the subsequent development of
heart disease with 5127
samples( 30 to 59 yrs ) at
Framingham.
• Study subjects were examined
every 2 yrs for 20 years.
• Daily Surveillance of
hospitalization at Framingham
hospital.
• Study found that Hypertensive,
tobacco smoking, elevated blood
cholesterol are associated to CHD
• Increased physical activity
associated with decreased risk of
CHD
11
Problem of prospective study
• Study might take long duration.
• Sufficient amount of funding for long period.
• Missing of study subjects.
12
Retrospective Cohort Study
• A retrospective cohort study is one in which the
outcome have all occurred before the start of
investigation.
• Investigator goes back to the past to select study
group from existing records of the past
employment, medical and other records and
traces them forward through time from the past
date fixed on the records usually to the present.
• Known with the name of Historical Cohort and
noncurrent cohort
13
Example of Retrospective Study
• Suppose that we began our
study on association between
smoking habit and lung cancer
in 2008
• Now we find that an old roster
of elementary schoolchildren
from 1988 is available in our
community, and that they had
been surveyed regarding their
smoking habits in 1998.
• Using these data resources in
2008, we can begin to
determine who in this
population has developed lung
cancer and who has not.
14
Ambi-directional cohort Study
• Elements of prospective and retrospective
cohort are combined.
• The Cohort is identified from past records and
assesses of date for the outcome. The same
cohort is the followed up prospectively into
future for the further assessment of outcome
15
Example of Ambi-directional cohort
study
• Curt- Brown and Dolls study on effects of
radiation Began in 1955 with 13,352 patients
who received large dose of radiation therapy for
ankylosing spondylitis between 1934 to1954.
• Outcome evaluated was death from Leukemia or
aplastic anemia between 1934 to 1954.
• A prospective component was added up in 1955
and surviving subjects were followed up to
identify deaths in subsequent years
16
Comparison of retrospective and prospective
cohort study
17
Prognostic cohort studies
Prognostic cohort studies are a special type of cohort study used
to identify factors that might influence the prognosis after a
diagnosis or treatment.
These follow-up studies have the following features:
The cohort consists of cases diagnosed at a fixed time, or cases
treated at a fixed time by a medical or surgical treatment,
rehabilitation procedure, psychological adjustment.
By definition, such cases are not free of a specified disease, as in
the case of a conventional cohort
The outcome of interest is usually survival, cure, improvement,
disability, or repeat episode of the illness, etc.
18
Steps of Cohort Study
19
1. Selection of study subjects
The usual procedure is to locate or identify the cohort,
which may be a total population in an area or sample
thereof. Cohort can be:
• community cohort of specific age and sex;
• exposure cohort e.g. radiologists, smokers, users of
oral contraceptives;
• birth cohort e.g. school entrants;
• occupational cohort e.g. miners, military personnel;
• marriage cohort;
• diagnosed or treated cohort, e.g. cases treated with
radiotherapy, surgery, hormonal treatment.
20
Open or dynamic cohort
• Open population or dynamic population describe a
population in which the person-time experience can
accrue from a changing roster of individuals.
• For example, in a study, the incidence rates of
cancer reported by the Connecticut Cancer Registry
come from the experience of an open population.
Because the population of residents of Connecticut
is always changing, the individuals who contribute
to these rates are not a specific set of people who
are followed through time.
21
Fixed and Closed Cohort
• Fixed Cohort :When the exposure groups in a
cohort study are defined at the start of follow-up,
with no movement of individuals between
exposure groups during the follow-up, the groups
are called fixed cohorts.
• If no losses occur from a fixed cohort, the cohort
satisfies the definition of a closed population and
is often called a closed cohort
22
2. Obtaining data on Exposure
• From Cohort Members : Personal interview,
mailed questionnaire
• Review of Records : Certain kinds of information
like dose of radiation, kinds of surgery received
can only be obtained from medical records.
• Medical examination/ Special tests: In some
cases information needs to be obtained from
medical examination like in case of blood
pressure, serum cholesterol,
• Environmental Survey of location where cohort
lives
23
Information should be collected in a manner
that allows classification of cohort according
to
• whether or not they have been exposed to
suspected factor
• According to level or degree of exposure
• Demographic variables which might influence
frequency of disease under investigation
24
3. Comparison Group
Internal Comparison
Group :
Single Cohort enters the
study and its members on
the basis of information
obtained , can be
classified into several
comparison according to
degree of exposure
Classification
of exposure
No. of
Deaths
Death rate
½ pack 24 95.2
½ to 1 pack 84 107.82
1-2 pack 90 229.2
+ 2 pack 97 264.2
Age Standardized death rate among
100000 men per year according to
amount of cigarette smoking
25
External Comparison Group: when information on
degree of exposure is not available.
if all workers at the factory had some degree of
exposure, we would need to select a comparison
group from another population, possibly another
type of factory
Comparison with general population can also be
used as comparison group
26
4. Follow UP
• The length of follow-up that is needed for
some studies to reach a satisfactory end-
point, when a large enough proportion of the
participants have reached an outcome, may
be many years or even decades.
• At the start of study, method should be
determined depending on the outcome of
study to obtain data for assessing outcome.
27
Procedure may be:
• Periodic medical examination of each member
of cohort
• Reviewing physician and hospital records
• Routine surveillance of death records
• Mailed questionnaire, telephone calls and
periodic home visits
28
5. Analysis
Data analyzed in terms of
• Incidence rate of outcome among exposed
and non exposed
• Estimation of risk
29
Incidence rate
Choice between cumulative incidence and Incidence Density
is a crucial issue
• Cumulative incidence: In cohort studies on acute diseases
with short induction periods and a short time of follow-up,
like outbreaks, the risk of disease can be estimated directly
using the cumulative incidence, given a fixed cohort with
fixed period of follow-up and a low fraction of drop-outs.
• Incidence Density: In cohort studies on chronic diseases
with their long follow-up periods, however, the use of the
cumulative incidence is not appropriate because usually
disease-free follow-up periods differ strongly among
cohort members. In such case incidence density is apposite
measure 30
Death No death Incidence
rate
Total
Exposed A B A/(A+B) A + B
Unexpos
ed
C D C/(C+D) C + D
Total A + C B + D A+B+C+
D
Outcome*
* Outcome : death/disease
ANALYSIS OF COHORT STUDIES
31
A = Exposed persons who later develop disease or die
B = Exposed persons who do not develop diseases or die
C = Unexposed persons who later develop disease or die
D = Unexposed persons who do not develop diseases or die
The total number of exposed persons = A + B
The total number of unexposed persons = C + D
Incidence of disease(or death) among exposed= A/A+B
Incidence of disease(or death) among non-exposed= C/C+D
32
Relative Risk (RR)
• Estimates the magnitude of an association between exposure
and disease
• Indicates the likelihood of developing the disease in the
exposed group relative to those who are not exposed
• Ratio of risk of disease in exposed to the risk of disease in
nonexposed
Relative Risk
RR =
Risk in exposed(Incidence in exposed group)
Risk in non exposed(Incidence in non exposed group)
33
EXAMPLE
34
Children
(<12 yrs)
1000
Family
smoker
500 children
Exposed
Family non-smoker
500 children
Not exposed
Diseased
300
Not diseased
200
Diseased
120
Not diseased
380
OutcomeStart
35
Rate: Incidence rate
•Incidence of Resp. Infection among exposed
children: 300
500 = 60%
•Incidence of Resp. Infect. Among non exposed
children: 120
500 = 24%
36
Cohort Study (cont.)Relative Risk: Incidence rate among exposed
Risk Ratio Incidence rate in non exposed.
60
24 = 2.5
Exposed individuals are 2.5 times more likely to
develop disease than non exposed individuals.
37
Difference Measures
• Attributable risk
– No. of cases among the exposed that could be eliminated
if the exposure were removed
= Incidence in exposed - Incidence in unexposed
• Population Attributable Risk percentage:
PAR expressed as a percentage of total risk
in population
100x
I
I-I
PAR%
population
unexposedpopulation
=
38
Attributable Risk
Incidence
Exposed Unexposed
Iexposed – Iunexposed
I = Incidence
39
Yes No Incidence RD
Yes 100 1900 2000 0.05
No 80 7920 8000 0.01
180 9820 10000
AR: Smoking and Lung cancer
Smoking
0.04
Lung Cancer
Attributable risk = Incidence in exposed - Incidence in unexposed
=0.5-0.1
=0.4
40
• Excess risk of disease in total population
attributable to exposure
• Reduction in risk which would be achieved if
population entirely unexposed
• Helps determining which exposures relevant
to public health in community
Population Attributable Risk (PAR)
unexposedpopulation I-IPAR =
41
Population Attributable Risk
Risk
Population Unexposed
unexposedpopulation I-I
Ipopln– Iunexposed
42
Yes No Risk
Yes 100 1900 2000 Incidence in exposed= 0.050
No 80 7920 8000 Incidence in unexposed=0.010
180 9820 10000 Incidence in population=0.018
PAR: Smoking
44%100x
0.018
0.010-0.018
PAR% ==
0.0080.010-0.018PAR ==
Smoking
Lung Cancer
43
Conclusion:
44% of lung cancer in the population could be
prevented if use of smoking were eliminated
44
But calculations
are
not that simple in real Cohort studies
45
British Doctors Study
• In 1951, a prospective cohort study was set up among British
doctors to investigate the relationship between smoking and
mortality, particularly the association between smoking and lung
cancer
• In 1951, a questionnaire on smoking habits was sent to 49,913 male
and 10,323 female doctors , 34,440 male doctors and 6194 female
doctors gave sufficient information to classify their smoking status.
• The causes of death of 10,072 male and 1094 female doctors who
had died during this period were ascertained from death
certificates.
• The rate of death from lung cancer among smokers was compared
to that among non-smokers.
46
47
Since mortality depends on age and the distribution of subjects by age group
is different between the smokers and non-smokers, the effect of age on
mortality has to be adjusted for when making comparison on lung cancer
mortality between these two groups. A commonly used method to adjust for
the age is direct standardization
48
It would not be rational to categorize individual
smoking one cigarette per day and more than 25
cigarette in same category with equal emphasis
So
Its better we opt for stratification
49
Again its not only the dose of exposure that determines the frequency of
disease, there are some other factors like duration of exposure and age at
initiation of exposure that can influence occurrence of disease. We need to
make adjustment for that too
50
The relative risk of lung cancer death increased with the level of smoking in
both males and females. The relative risk in the men smoking 1–14 and 15–
24 cigarettes per day is much higher than in the women; in the group
smoking 25 or more cigarettes per day, the relative risk in men is marginally
less than that in women. Does this mean that the effect of low levels of
smoking is higher among men than among women?
51
The proportion of men inhaling smoke is higher than women in all three levels of
smoking. Men seemed to have started to smoke at an earlier age than women.
Since these features of smoking may modify the effect of smoking on lung cancer,
their effects have to be adjusted for when comparing the association between
smoking and lung cancer in men and women.
52
…….. too complicated ????
But
Problem does not end here….
53
What if, a subject is followed up from age 23 but has been exposed from age 19
on, he|she is exposed until age 27 followed by an unexposed 5 year period. He|she is
again exposed until age 39 at which time his|her person-time at risk ceases either
because of disease diagnosis or because of end of follow-up.
54
For analyzing such data we use Poisson models
and Cox Proportional Hazards
Specialized software packages exist to perform
these computations such as Stata (Version 7
or later and Epicure
55
Advantage of Cohort Studies
• Temporality can be established
• Incidence ca be calculated.
• Several possible outcome related to exposure
can be studied simultaneously.
• Provide direct estimate of risk.
• Since comparison groups are formed before
disease develops certain forms of bias can be
minimized like misclassification bias.
• Allows the conclusion of cause effect
relationship 56
Disadvantage of Cohort Studies
• Large population is needed
• Not suitable for rare diseases.
• It is time consuming and expensive
• Certain administrative problems like loss of staff,
loss of funding and extensive record keeping are
common.
• Problem of attrition of initial cohort is common
• Study itself may alter people’s behavior
57
Ethics in Cohort Study
• Classic example issues on research ethics is
Tuskegee study on natural history of syphilis in
which US Public health service recruited 399 poor
black sharecroppers in Macon County as cohort.
• Study was lasted from 1932 to 1972.
• They were denied of treatment of syphilis
although effective treatment was available.
Government deceived by saying that they were
being treated.
58
Ethics in Cohort Study
• On July 26, 1972, The New York Times described
the study as “the longest non therapeutic
experiment on human beings in medical history.”
The disclosure of this study by the press was a
major scandal in the United States.
• Led to The Belmont Report: Ethical Principles and
Guidelines for the Protection of Human Subjects in
Research
59
Ethics in Cohort Study
• These problems can be encountered in cohort
study designed to study natural history of disease.
• What if treatment becomes available in the
middle of research, should we continue research
with treatment denial of abort research?
• Should we communicate the research finding to
individuals are controversial issues.
60
Biases in cohort study
Differential loss of follow up
Differential follow-up between compared groups
may be a major problem. Losses to follow-up,
whether due to study withdrawals, unmeasured
outcomes, or unknown reasons, are always a
concern.
This is particularly true when more outcome data is
missing in one group than another, as there is no
way to be certain that the factor being studied is
not somehow related to this observation.
61
Contamination
Subjects initially unexposed to the risk factor of
interest may become exposed at a later date.
Such “ contamination ” tends to reduce the
observed effect of the risk factor.
62
Selection Bias
Perhaps the largest threat to the internal validity of a
cohort studies is selection bias, also called case-mix
bias .
Select participants into exposed and not exposed groups
based on some characteristics that may affect the
outcome
Information bias−
Collect different quality and extent of information from
exposed and not exposed groups
63
Misclassification Bias
Differential misclassification
Non differential misclassification
64
• Differential misclassification – Errors in
measurement are one way only
– Example: Measurement bias – instrumentation may
be inaccurate, same cut off level of weight for male
and female to determine malnourishment
65
Misclassification Bias (cont.)
250100150
1005050Nonexposed
15050100Exposed
TotalDisease-Disease +
RR = a/(a+b)/c/(c+d) = 1.3
True Classification
250100150
905040Nonexposed
16050110Exposed
TotalDisease -Disease +
RR = a/(a+b)/c/(c+d) = 1.6
Differential misclassification - Overestimate exposure
for 10 cases, inflate rates
66
• Nondifferential (random) misclassification –
errors in assignment of group happens in more than
one direction
– This will dilute the study findings -
BIAS TOWARD THE NULL
67
Misclassification Bias (cont.)
Disease + Disease - Total
Exposed 100 50 150
Nonexposed 50 50 100
150 100 250
RR = a/(a+b)/c/(c+d) = 1.3
True Classification
Disease + Disease - Total
Exposed 110 60 170
Nonexposed 40 40 80
150 100 250
RR = a/(a+b)/c/(c+d) = 1.3
Nondifferential misclassification - Overestimate
exposure in 10 cases, 10 controls – bias towards null
68
Control of Bias
• Restriction
• Stratification
• Mathematical Modeling
-Poisson regression model
-Cox proportional hazard
69
When Is a Cohort Study Warranted?
• When the (alleged) exposure is known
• When exposure is rare and incidence of disease
among exposed is high (even if the exposure is
rare, determined investigators will identify
exposed individuals)
• When the time between exposure and disease is
relatively short
• When adequate funding is available
• When the investigator has a long life expectancy
70
Reference
• Park.k.,(2007), Park’s textbook of preventive and
social medicine(19th
edition)
• Gordis.L.,(2008), Epidemiology.,(4th
edition)
• Framimgham Heart study retrived from
www.framingham.com/heart/timeline.htm,on 29th
Jan,2011.
71
THANK YOU
72
Classic example of Cohort study :
Study on London Cholera Outbreak
• The classical study on the London cholera
epidemic of 1849 conducted by John Snow is an
example of a cohort study on infectious diseases .
• Two different water companies (the Lambeth and
the Southwark & Vauxhall) supplied households
within various regions of London
73
Classic example of Cohort study :
Study on London Cholera Outbreak
• The companies differed in one important feature, the
location of the water intake. The Lambeth had moved their
water intake upstream from the sewage discharge point in
1849; whereas, the Southwark & Vauxhall continued to
obtain water downstream of the sewage discharge point.
• Dr. Snow classified households according to their exposure
to the two water sources and showed a substantial
difference in cholera mortality, 315 versus 37 cholera
deaths per 10,000 households served by the Lambeth and
Southwark & Vauxhall companies, respectively.
74
Summary of analysis
75

More Related Content

What's hot

Study designs, Epidemiological study design, Types of studies
Study designs, Epidemiological study design, Types of studiesStudy designs, Epidemiological study design, Types of studies
Study designs, Epidemiological study design, Types of studiesDr Lipilekha Patnaik
 
Case control study
Case control studyCase control study
Case control studyTimiresh Das
 
Non randomized controlled trial
Non randomized controlled trial Non randomized controlled trial
Non randomized controlled trial HimikaRathi
 
Biases in epidemiology
Biases in epidemiologyBiases in epidemiology
Biases in epidemiologySubraham Pany
 
Bias and confounding
Bias and confoundingBias and confounding
Bias and confoundingIkram Ullah
 
Randomised Controlled Trial, RCT, Experimental study
Randomised Controlled Trial, RCT, Experimental studyRandomised Controlled Trial, RCT, Experimental study
Randomised Controlled Trial, RCT, Experimental studyDr Lipilekha Patnaik
 
Criteria for causal association
Criteria for causal associationCriteria for causal association
Criteria for causal associationdrkaushikp
 
Observational study
Observational  study Observational  study
Observational study GamitKinjal
 
Blinding in clinical trilas
Blinding in clinical trilas Blinding in clinical trilas
Blinding in clinical trilas Tarek Tawfik Amin
 
Study design in research
Study design in  research Study design in  research
Study design in research Kusum Gaur
 
Epidemiological study designs
Epidemiological study designs Epidemiological study designs
Epidemiological study designs Tauseef Jawaid
 

What's hot (20)

Case control study
Case control studyCase control study
Case control study
 
Study designs, Epidemiological study design, Types of studies
Study designs, Epidemiological study design, Types of studiesStudy designs, Epidemiological study design, Types of studies
Study designs, Epidemiological study design, Types of studies
 
Randomized Controlled Trial
Randomized Controlled TrialRandomized Controlled Trial
Randomized Controlled Trial
 
Cross sectional study
Cross sectional studyCross sectional study
Cross sectional study
 
Bias in clinical research
Bias in clinical research Bias in clinical research
Bias in clinical research
 
Epidemiological studies
Epidemiological studiesEpidemiological studies
Epidemiological studies
 
Case control study
Case control studyCase control study
Case control study
 
Cross sectional study
Cross sectional studyCross sectional study
Cross sectional study
 
Non randomized controlled trial
Non randomized controlled trial Non randomized controlled trial
Non randomized controlled trial
 
Biases in epidemiology
Biases in epidemiologyBiases in epidemiology
Biases in epidemiology
 
Bias and confounding
Bias and confoundingBias and confounding
Bias and confounding
 
Randomised Controlled Trial, RCT, Experimental study
Randomised Controlled Trial, RCT, Experimental studyRandomised Controlled Trial, RCT, Experimental study
Randomised Controlled Trial, RCT, Experimental study
 
Study designs
Study designsStudy designs
Study designs
 
Criteria for causal association
Criteria for causal associationCriteria for causal association
Criteria for causal association
 
Bias and errors
Bias and errorsBias and errors
Bias and errors
 
Observational study
Observational  study Observational  study
Observational study
 
5. cohort studies
5. cohort  studies5. cohort  studies
5. cohort studies
 
Blinding in clinical trilas
Blinding in clinical trilas Blinding in clinical trilas
Blinding in clinical trilas
 
Study design in research
Study design in  research Study design in  research
Study design in research
 
Epidemiological study designs
Epidemiological study designs Epidemiological study designs
Epidemiological study designs
 

Viewers also liked

Cohort study - basics
Cohort study - basicsCohort study - basics
Cohort study - basicsRizwan S A
 
Calculating Customer Lifetime Value: From Analysis to Loyalty
Calculating Customer Lifetime Value: From Analysis to LoyaltyCalculating Customer Lifetime Value: From Analysis to Loyalty
Calculating Customer Lifetime Value: From Analysis to LoyaltyLooker
 
New definition of oral health
New definition of oral healthNew definition of oral health
New definition of oral healthVineetha K
 
Customer Acquisition Cost and Lifetime Value (CAC & LTV)
Customer Acquisition Cost and Lifetime Value (CAC & LTV)Customer Acquisition Cost and Lifetime Value (CAC & LTV)
Customer Acquisition Cost and Lifetime Value (CAC & LTV)Sarah Wilz, M.Ed
 
Case Control Studies
Case Control StudiesCase Control Studies
Case Control StudiesRachel Walden
 
Redox Reactions
Redox ReactionsRedox Reactions
Redox ReactionsArrehome
 
Epidemiological Studies
Epidemiological StudiesEpidemiological Studies
Epidemiological StudiesINAAMUL HAQ
 
2 Research and Impact Lessons from Young Lives Cohort Study, Paul Dornan
2 Research and Impact Lessons from Young Lives Cohort Study, Paul Dornan2 Research and Impact Lessons from Young Lives Cohort Study, Paul Dornan
2 Research and Impact Lessons from Young Lives Cohort Study, Paul DornanThe Impact Initiative
 
Crp critical appraisal group 9 cohort
Crp   critical appraisal group 9 cohortCrp   critical appraisal group 9 cohort
Crp critical appraisal group 9 cohortMuhammadNuurFauzi
 
Measurement risk and the impact on your processes
Measurement risk and the impact on your processes  Measurement risk and the impact on your processes
Measurement risk and the impact on your processes Transcat
 
Farmacoepi Course Leiden 0210 Part 2
Farmacoepi Course Leiden 0210   Part 2Farmacoepi Course Leiden 0210   Part 2
Farmacoepi Course Leiden 0210 Part 2RobHeerdink
 
Redox titrations [compatibility mode]
Redox titrations [compatibility mode]Redox titrations [compatibility mode]
Redox titrations [compatibility mode]Lujain AL-Ashqar
 
Conductometry titration
Conductometry titrationConductometry titration
Conductometry titrationKrishna Kumar
 
2 Redox Titrations
2 Redox Titrations2 Redox Titrations
2 Redox Titrationsjanetra
 
A step by-step guide to calculating customer lifetime value
A step by-step guide to calculating customer lifetime valueA step by-step guide to calculating customer lifetime value
A step by-step guide to calculating customer lifetime valueGeoff Fripp
 
How to stand out online
How to stand out onlineHow to stand out online
How to stand out onlineMars Dorian
 

Viewers also liked (20)

Cohort study - basics
Cohort study - basicsCohort study - basics
Cohort study - basics
 
Calculating Customer Lifetime Value: From Analysis to Loyalty
Calculating Customer Lifetime Value: From Analysis to LoyaltyCalculating Customer Lifetime Value: From Analysis to Loyalty
Calculating Customer Lifetime Value: From Analysis to Loyalty
 
New definition of oral health
New definition of oral healthNew definition of oral health
New definition of oral health
 
Customer Acquisition Cost and Lifetime Value (CAC & LTV)
Customer Acquisition Cost and Lifetime Value (CAC & LTV)Customer Acquisition Cost and Lifetime Value (CAC & LTV)
Customer Acquisition Cost and Lifetime Value (CAC & LTV)
 
Case Control Studies
Case Control StudiesCase Control Studies
Case Control Studies
 
Redox Reactions
Redox ReactionsRedox Reactions
Redox Reactions
 
Diabetes pathology
Diabetes pathologyDiabetes pathology
Diabetes pathology
 
Epidemiological Studies
Epidemiological StudiesEpidemiological Studies
Epidemiological Studies
 
2 Research and Impact Lessons from Young Lives Cohort Study, Paul Dornan
2 Research and Impact Lessons from Young Lives Cohort Study, Paul Dornan2 Research and Impact Lessons from Young Lives Cohort Study, Paul Dornan
2 Research and Impact Lessons from Young Lives Cohort Study, Paul Dornan
 
Cohort study
Cohort studyCohort study
Cohort study
 
Crp critical appraisal group 9 cohort
Crp   critical appraisal group 9 cohortCrp   critical appraisal group 9 cohort
Crp critical appraisal group 9 cohort
 
Measurement risk and the impact on your processes
Measurement risk and the impact on your processes  Measurement risk and the impact on your processes
Measurement risk and the impact on your processes
 
Farmacoepi Course Leiden 0210 Part 2
Farmacoepi Course Leiden 0210   Part 2Farmacoepi Course Leiden 0210   Part 2
Farmacoepi Course Leiden 0210 Part 2
 
Redox titrations [compatibility mode]
Redox titrations [compatibility mode]Redox titrations [compatibility mode]
Redox titrations [compatibility mode]
 
Conductometry titration
Conductometry titrationConductometry titration
Conductometry titration
 
2 Redox Titrations
2 Redox Titrations2 Redox Titrations
2 Redox Titrations
 
Redox reactions
Redox reactionsRedox reactions
Redox reactions
 
A step by-step guide to calculating customer lifetime value
A step by-step guide to calculating customer lifetime valueA step by-step guide to calculating customer lifetime value
A step by-step guide to calculating customer lifetime value
 
How to stand out online
How to stand out onlineHow to stand out online
How to stand out online
 
2012 and We're STILL Using PowerPoint Wrong
2012 and We're STILL Using PowerPoint Wrong2012 and We're STILL Using PowerPoint Wrong
2012 and We're STILL Using PowerPoint Wrong
 

Similar to Cohort Study

Observational analytical and interventional studies
Observational analytical and interventional studiesObservational analytical and interventional studies
Observational analytical and interventional studiesAchyut Raj Pandey
 
Cohort studies with example of classical cohort studies
Cohort studies with example of classical cohort studiesCohort studies with example of classical cohort studies
Cohort studies with example of classical cohort studiesshefali jain
 
Fundamentals of clinical research and experimental design, Prof. Usama M.Fouda
Fundamentals of clinical research and experimental design, Prof. Usama M.Fouda Fundamentals of clinical research and experimental design, Prof. Usama M.Fouda
Fundamentals of clinical research and experimental design, Prof. Usama M.Fouda umfrfouda
 
Cohort Studies by Dr. Mohammed Jawad 2020
Cohort Studies by Dr. Mohammed Jawad 2020Cohort Studies by Dr. Mohammed Jawad 2020
Cohort Studies by Dr. Mohammed Jawad 2020Kadium
 
Epidemiological concept
Epidemiological conceptEpidemiological concept
Epidemiological conceptsushantkarki4
 
ANALYTICAL STUDIES.pptx
ANALYTICAL STUDIES.pptxANALYTICAL STUDIES.pptx
ANALYTICAL STUDIES.pptxpayalrathod14
 
Chapter seven. epidemiologic study designs
Chapter seven. epidemiologic study designsChapter seven. epidemiologic study designs
Chapter seven. epidemiologic study designsOmar Osman Eid
 
Clinical trial : Types and Design (Pharmacovigilance)
Clinical trial : Types and Design (Pharmacovigilance)Clinical trial : Types and Design (Pharmacovigilance)
Clinical trial : Types and Design (Pharmacovigilance)Ayush Roy
 
Experimental Studies
Experimental StudiesExperimental Studies
Experimental StudiesAbhijit Das
 
Cohort study
Cohort study Cohort study
Cohort study soudfaiza
 
observational analytical and interventional studies
observational analytical and interventional studiesobservational analytical and interventional studies
observational analytical and interventional studiesvikasaagrahari007
 
STUDY DESIGN in health and medical research .pptx
STUDY DESIGN in health and medical research .pptxSTUDY DESIGN in health and medical research .pptx
STUDY DESIGN in health and medical research .pptxAbubakar Hammadama
 

Similar to Cohort Study (20)

Cohort Studymnk.pptx
Cohort Studymnk.pptxCohort Studymnk.pptx
Cohort Studymnk.pptx
 
Observational analytical and interventional studies
Observational analytical and interventional studiesObservational analytical and interventional studies
Observational analytical and interventional studies
 
cohort study
 cohort study cohort study
cohort study
 
Cohort study
Cohort studyCohort study
Cohort study
 
Cohort studies with example of classical cohort studies
Cohort studies with example of classical cohort studiesCohort studies with example of classical cohort studies
Cohort studies with example of classical cohort studies
 
Fundamentals of clinical research and experimental design, Prof. Usama M.Fouda
Fundamentals of clinical research and experimental design, Prof. Usama M.Fouda Fundamentals of clinical research and experimental design, Prof. Usama M.Fouda
Fundamentals of clinical research and experimental design, Prof. Usama M.Fouda
 
Cohort Studies by Dr. Mohammed Jawad 2020
Cohort Studies by Dr. Mohammed Jawad 2020Cohort Studies by Dr. Mohammed Jawad 2020
Cohort Studies by Dr. Mohammed Jawad 2020
 
Epidemiological concept
Epidemiological conceptEpidemiological concept
Epidemiological concept
 
ANALYTICAL STUDIES.pptx
ANALYTICAL STUDIES.pptxANALYTICAL STUDIES.pptx
ANALYTICAL STUDIES.pptx
 
Observational study design
Observational study designObservational study design
Observational study design
 
Chapter seven. epidemiologic study designs
Chapter seven. epidemiologic study designsChapter seven. epidemiologic study designs
Chapter seven. epidemiologic study designs
 
Clinical trial : Types and Design (Pharmacovigilance)
Clinical trial : Types and Design (Pharmacovigilance)Clinical trial : Types and Design (Pharmacovigilance)
Clinical trial : Types and Design (Pharmacovigilance)
 
BIOSTAT_GROUP-5-Section-7.pptx
BIOSTAT_GROUP-5-Section-7.pptxBIOSTAT_GROUP-5-Section-7.pptx
BIOSTAT_GROUP-5-Section-7.pptx
 
4. Cohort
4. Cohort4. Cohort
4. Cohort
 
COHORT STUDY
COHORT STUDY COHORT STUDY
COHORT STUDY
 
Experimental Studies
Experimental StudiesExperimental Studies
Experimental Studies
 
CT Screening for Lung Cancer
CT Screening for Lung CancerCT Screening for Lung Cancer
CT Screening for Lung Cancer
 
Cohort study
Cohort study Cohort study
Cohort study
 
observational analytical and interventional studies
observational analytical and interventional studiesobservational analytical and interventional studies
observational analytical and interventional studies
 
STUDY DESIGN in health and medical research .pptx
STUDY DESIGN in health and medical research .pptxSTUDY DESIGN in health and medical research .pptx
STUDY DESIGN in health and medical research .pptx
 

Recently uploaded

Earth Day Presentation wow hello nice great
Earth Day Presentation wow hello nice greatEarth Day Presentation wow hello nice great
Earth Day Presentation wow hello nice greatYousafMalik24
 
GRADE 4 - SUMMATIVE TEST QUARTER 4 ALL SUBJECTS
GRADE 4 - SUMMATIVE TEST QUARTER 4 ALL SUBJECTSGRADE 4 - SUMMATIVE TEST QUARTER 4 ALL SUBJECTS
GRADE 4 - SUMMATIVE TEST QUARTER 4 ALL SUBJECTSJoshuaGantuangco2
 
Difference Between Search & Browse Methods in Odoo 17
Difference Between Search & Browse Methods in Odoo 17Difference Between Search & Browse Methods in Odoo 17
Difference Between Search & Browse Methods in Odoo 17Celine George
 
AMERICAN LANGUAGE HUB_Level2_Student'sBook_Answerkey.pdf
AMERICAN LANGUAGE HUB_Level2_Student'sBook_Answerkey.pdfAMERICAN LANGUAGE HUB_Level2_Student'sBook_Answerkey.pdf
AMERICAN LANGUAGE HUB_Level2_Student'sBook_Answerkey.pdfphamnguyenenglishnb
 
MULTIDISCIPLINRY NATURE OF THE ENVIRONMENTAL STUDIES.pptx
MULTIDISCIPLINRY NATURE OF THE ENVIRONMENTAL STUDIES.pptxMULTIDISCIPLINRY NATURE OF THE ENVIRONMENTAL STUDIES.pptx
MULTIDISCIPLINRY NATURE OF THE ENVIRONMENTAL STUDIES.pptxAnupkumar Sharma
 
ANG SEKTOR NG agrikultura.pptx QUARTER 4
ANG SEKTOR NG agrikultura.pptx QUARTER 4ANG SEKTOR NG agrikultura.pptx QUARTER 4
ANG SEKTOR NG agrikultura.pptx QUARTER 4MiaBumagat1
 
Science 7 Quarter 4 Module 2: Natural Resources.pptx
Science 7 Quarter 4 Module 2: Natural Resources.pptxScience 7 Quarter 4 Module 2: Natural Resources.pptx
Science 7 Quarter 4 Module 2: Natural Resources.pptxMaryGraceBautista27
 
Field Attribute Index Feature in Odoo 17
Field Attribute Index Feature in Odoo 17Field Attribute Index Feature in Odoo 17
Field Attribute Index Feature in Odoo 17Celine George
 
Like-prefer-love -hate+verb+ing & silent letters & citizenship text.pdf
Like-prefer-love -hate+verb+ing & silent letters & citizenship text.pdfLike-prefer-love -hate+verb+ing & silent letters & citizenship text.pdf
Like-prefer-love -hate+verb+ing & silent letters & citizenship text.pdfMr Bounab Samir
 
AUDIENCE THEORY -CULTIVATION THEORY - GERBNER.pptx
AUDIENCE THEORY -CULTIVATION THEORY -  GERBNER.pptxAUDIENCE THEORY -CULTIVATION THEORY -  GERBNER.pptx
AUDIENCE THEORY -CULTIVATION THEORY - GERBNER.pptxiammrhaywood
 
ISYU TUNGKOL SA SEKSWLADIDA (ISSUE ABOUT SEXUALITY
ISYU TUNGKOL SA SEKSWLADIDA (ISSUE ABOUT SEXUALITYISYU TUNGKOL SA SEKSWLADIDA (ISSUE ABOUT SEXUALITY
ISYU TUNGKOL SA SEKSWLADIDA (ISSUE ABOUT SEXUALITYKayeClaireEstoconing
 
FILIPINO PSYCHology sikolohiyang pilipino
FILIPINO PSYCHology sikolohiyang pilipinoFILIPINO PSYCHology sikolohiyang pilipino
FILIPINO PSYCHology sikolohiyang pilipinojohnmickonozaleda
 
INTRODUCTION TO CATHOLIC CHRISTOLOGY.pptx
INTRODUCTION TO CATHOLIC CHRISTOLOGY.pptxINTRODUCTION TO CATHOLIC CHRISTOLOGY.pptx
INTRODUCTION TO CATHOLIC CHRISTOLOGY.pptxHumphrey A Beña
 
Barangay Council for the Protection of Children (BCPC) Orientation.pptx
Barangay Council for the Protection of Children (BCPC) Orientation.pptxBarangay Council for the Protection of Children (BCPC) Orientation.pptx
Barangay Council for the Protection of Children (BCPC) Orientation.pptxCarlos105
 
USPS® Forced Meter Migration - How to Know if Your Postage Meter Will Soon be...
USPS® Forced Meter Migration - How to Know if Your Postage Meter Will Soon be...USPS® Forced Meter Migration - How to Know if Your Postage Meter Will Soon be...
USPS® Forced Meter Migration - How to Know if Your Postage Meter Will Soon be...Postal Advocate Inc.
 
Choosing the Right CBSE School A Comprehensive Guide for Parents
Choosing the Right CBSE School A Comprehensive Guide for ParentsChoosing the Right CBSE School A Comprehensive Guide for Parents
Choosing the Right CBSE School A Comprehensive Guide for Parentsnavabharathschool99
 
Culture Uniformity or Diversity IN SOCIOLOGY.pptx
Culture Uniformity or Diversity IN SOCIOLOGY.pptxCulture Uniformity or Diversity IN SOCIOLOGY.pptx
Culture Uniformity or Diversity IN SOCIOLOGY.pptxPoojaSen20
 
Keynote by Prof. Wurzer at Nordex about IP-design
Keynote by Prof. Wurzer at Nordex about IP-designKeynote by Prof. Wurzer at Nordex about IP-design
Keynote by Prof. Wurzer at Nordex about IP-designMIPLM
 

Recently uploaded (20)

Earth Day Presentation wow hello nice great
Earth Day Presentation wow hello nice greatEarth Day Presentation wow hello nice great
Earth Day Presentation wow hello nice great
 
GRADE 4 - SUMMATIVE TEST QUARTER 4 ALL SUBJECTS
GRADE 4 - SUMMATIVE TEST QUARTER 4 ALL SUBJECTSGRADE 4 - SUMMATIVE TEST QUARTER 4 ALL SUBJECTS
GRADE 4 - SUMMATIVE TEST QUARTER 4 ALL SUBJECTS
 
FINALS_OF_LEFT_ON_C'N_EL_DORADO_2024.pptx
FINALS_OF_LEFT_ON_C'N_EL_DORADO_2024.pptxFINALS_OF_LEFT_ON_C'N_EL_DORADO_2024.pptx
FINALS_OF_LEFT_ON_C'N_EL_DORADO_2024.pptx
 
Difference Between Search & Browse Methods in Odoo 17
Difference Between Search & Browse Methods in Odoo 17Difference Between Search & Browse Methods in Odoo 17
Difference Between Search & Browse Methods in Odoo 17
 
AMERICAN LANGUAGE HUB_Level2_Student'sBook_Answerkey.pdf
AMERICAN LANGUAGE HUB_Level2_Student'sBook_Answerkey.pdfAMERICAN LANGUAGE HUB_Level2_Student'sBook_Answerkey.pdf
AMERICAN LANGUAGE HUB_Level2_Student'sBook_Answerkey.pdf
 
MULTIDISCIPLINRY NATURE OF THE ENVIRONMENTAL STUDIES.pptx
MULTIDISCIPLINRY NATURE OF THE ENVIRONMENTAL STUDIES.pptxMULTIDISCIPLINRY NATURE OF THE ENVIRONMENTAL STUDIES.pptx
MULTIDISCIPLINRY NATURE OF THE ENVIRONMENTAL STUDIES.pptx
 
ANG SEKTOR NG agrikultura.pptx QUARTER 4
ANG SEKTOR NG agrikultura.pptx QUARTER 4ANG SEKTOR NG agrikultura.pptx QUARTER 4
ANG SEKTOR NG agrikultura.pptx QUARTER 4
 
Science 7 Quarter 4 Module 2: Natural Resources.pptx
Science 7 Quarter 4 Module 2: Natural Resources.pptxScience 7 Quarter 4 Module 2: Natural Resources.pptx
Science 7 Quarter 4 Module 2: Natural Resources.pptx
 
Field Attribute Index Feature in Odoo 17
Field Attribute Index Feature in Odoo 17Field Attribute Index Feature in Odoo 17
Field Attribute Index Feature in Odoo 17
 
Like-prefer-love -hate+verb+ing & silent letters & citizenship text.pdf
Like-prefer-love -hate+verb+ing & silent letters & citizenship text.pdfLike-prefer-love -hate+verb+ing & silent letters & citizenship text.pdf
Like-prefer-love -hate+verb+ing & silent letters & citizenship text.pdf
 
AUDIENCE THEORY -CULTIVATION THEORY - GERBNER.pptx
AUDIENCE THEORY -CULTIVATION THEORY -  GERBNER.pptxAUDIENCE THEORY -CULTIVATION THEORY -  GERBNER.pptx
AUDIENCE THEORY -CULTIVATION THEORY - GERBNER.pptx
 
ISYU TUNGKOL SA SEKSWLADIDA (ISSUE ABOUT SEXUALITY
ISYU TUNGKOL SA SEKSWLADIDA (ISSUE ABOUT SEXUALITYISYU TUNGKOL SA SEKSWLADIDA (ISSUE ABOUT SEXUALITY
ISYU TUNGKOL SA SEKSWLADIDA (ISSUE ABOUT SEXUALITY
 
FILIPINO PSYCHology sikolohiyang pilipino
FILIPINO PSYCHology sikolohiyang pilipinoFILIPINO PSYCHology sikolohiyang pilipino
FILIPINO PSYCHology sikolohiyang pilipino
 
LEFT_ON_C'N_ PRELIMS_EL_DORADO_2024.pptx
LEFT_ON_C'N_ PRELIMS_EL_DORADO_2024.pptxLEFT_ON_C'N_ PRELIMS_EL_DORADO_2024.pptx
LEFT_ON_C'N_ PRELIMS_EL_DORADO_2024.pptx
 
INTRODUCTION TO CATHOLIC CHRISTOLOGY.pptx
INTRODUCTION TO CATHOLIC CHRISTOLOGY.pptxINTRODUCTION TO CATHOLIC CHRISTOLOGY.pptx
INTRODUCTION TO CATHOLIC CHRISTOLOGY.pptx
 
Barangay Council for the Protection of Children (BCPC) Orientation.pptx
Barangay Council for the Protection of Children (BCPC) Orientation.pptxBarangay Council for the Protection of Children (BCPC) Orientation.pptx
Barangay Council for the Protection of Children (BCPC) Orientation.pptx
 
USPS® Forced Meter Migration - How to Know if Your Postage Meter Will Soon be...
USPS® Forced Meter Migration - How to Know if Your Postage Meter Will Soon be...USPS® Forced Meter Migration - How to Know if Your Postage Meter Will Soon be...
USPS® Forced Meter Migration - How to Know if Your Postage Meter Will Soon be...
 
Choosing the Right CBSE School A Comprehensive Guide for Parents
Choosing the Right CBSE School A Comprehensive Guide for ParentsChoosing the Right CBSE School A Comprehensive Guide for Parents
Choosing the Right CBSE School A Comprehensive Guide for Parents
 
Culture Uniformity or Diversity IN SOCIOLOGY.pptx
Culture Uniformity or Diversity IN SOCIOLOGY.pptxCulture Uniformity or Diversity IN SOCIOLOGY.pptx
Culture Uniformity or Diversity IN SOCIOLOGY.pptx
 
Keynote by Prof. Wurzer at Nordex about IP-design
Keynote by Prof. Wurzer at Nordex about IP-designKeynote by Prof. Wurzer at Nordex about IP-design
Keynote by Prof. Wurzer at Nordex about IP-design
 

Cohort Study

  • 1. Cohort Study Achyut Raj Pandey Nepal Health Research Council 1
  • 2. Concept of cohort The word cohort is derived from the Latin “cohorts” meaning an enclosure, company, or crowd. In Roman times a cohort was a body of 300–600 infantry. In epidemiological terms the cohort is a group of people with something in common, usually an exposure or involvement in a defined population group. 2
  • 3. Definition • Cohort study is a type of analytical study which is undertaken to obtain additional evidence to refute or support existence of association between suspected cause and diseases. • Other names of cohort study are Longitudinal study, Incidence study and forward looking study 3
  • 4. Features of cohort studies • Cohorts are identified prior to appearance of disease under investigation • The study groups are observed over a period of time to determine the frequency of disease among them • The study proceeds from cause to effects 4
  • 5. Indications for cohort study • There is good evidence of an association between exposure and disease, from other studies. • Exposure is rare. • Attrition of study population can be minimized. • Sufficient fund is available. 5
  • 7. Design of Cohort Study Then (a+b) is called study cohort and (c+d) is called control cohort 7
  • 8. Consideration during selection of Cohort • The cohort must be free from disease under study. • Insofar as the knowledge permits, both the groups should be equally susceptible to disease under study. • Both the groups must be comparable in respect of all variable which influence the occurrence of disease • Diagnostic and eligibility criteria of the disease must be defined beforehand. 8
  • 9. Types of cohort study • Prospective study • Retrospective cohort study • Ambi-directional cohort study 9
  • 10. Prospective cohort study • The common strategy of cohort studies is to start with a reference population (or a representative sample thereof), some of whom have certain characteristics or attributes relevant to the study (exposed group), with others who do not have those characteristics (unexposed group). • Both groups should, at the outset of the study, be free from the condition under consideration. Both groups are then observed over a specified period to find out the risk each group has of developing the condition(s) of interest. 10
  • 11. Example of Prospective Cohort Study Framingham Heart Study Framework • Initiated in 1948 to study the relationship of a variety of factors to the subsequent development of heart disease with 5127 samples( 30 to 59 yrs ) at Framingham. • Study subjects were examined every 2 yrs for 20 years. • Daily Surveillance of hospitalization at Framingham hospital. • Study found that Hypertensive, tobacco smoking, elevated blood cholesterol are associated to CHD • Increased physical activity associated with decreased risk of CHD 11
  • 12. Problem of prospective study • Study might take long duration. • Sufficient amount of funding for long period. • Missing of study subjects. 12
  • 13. Retrospective Cohort Study • A retrospective cohort study is one in which the outcome have all occurred before the start of investigation. • Investigator goes back to the past to select study group from existing records of the past employment, medical and other records and traces them forward through time from the past date fixed on the records usually to the present. • Known with the name of Historical Cohort and noncurrent cohort 13
  • 14. Example of Retrospective Study • Suppose that we began our study on association between smoking habit and lung cancer in 2008 • Now we find that an old roster of elementary schoolchildren from 1988 is available in our community, and that they had been surveyed regarding their smoking habits in 1998. • Using these data resources in 2008, we can begin to determine who in this population has developed lung cancer and who has not. 14
  • 15. Ambi-directional cohort Study • Elements of prospective and retrospective cohort are combined. • The Cohort is identified from past records and assesses of date for the outcome. The same cohort is the followed up prospectively into future for the further assessment of outcome 15
  • 16. Example of Ambi-directional cohort study • Curt- Brown and Dolls study on effects of radiation Began in 1955 with 13,352 patients who received large dose of radiation therapy for ankylosing spondylitis between 1934 to1954. • Outcome evaluated was death from Leukemia or aplastic anemia between 1934 to 1954. • A prospective component was added up in 1955 and surviving subjects were followed up to identify deaths in subsequent years 16
  • 17. Comparison of retrospective and prospective cohort study 17
  • 18. Prognostic cohort studies Prognostic cohort studies are a special type of cohort study used to identify factors that might influence the prognosis after a diagnosis or treatment. These follow-up studies have the following features: The cohort consists of cases diagnosed at a fixed time, or cases treated at a fixed time by a medical or surgical treatment, rehabilitation procedure, psychological adjustment. By definition, such cases are not free of a specified disease, as in the case of a conventional cohort The outcome of interest is usually survival, cure, improvement, disability, or repeat episode of the illness, etc. 18
  • 19. Steps of Cohort Study 19
  • 20. 1. Selection of study subjects The usual procedure is to locate or identify the cohort, which may be a total population in an area or sample thereof. Cohort can be: • community cohort of specific age and sex; • exposure cohort e.g. radiologists, smokers, users of oral contraceptives; • birth cohort e.g. school entrants; • occupational cohort e.g. miners, military personnel; • marriage cohort; • diagnosed or treated cohort, e.g. cases treated with radiotherapy, surgery, hormonal treatment. 20
  • 21. Open or dynamic cohort • Open population or dynamic population describe a population in which the person-time experience can accrue from a changing roster of individuals. • For example, in a study, the incidence rates of cancer reported by the Connecticut Cancer Registry come from the experience of an open population. Because the population of residents of Connecticut is always changing, the individuals who contribute to these rates are not a specific set of people who are followed through time. 21
  • 22. Fixed and Closed Cohort • Fixed Cohort :When the exposure groups in a cohort study are defined at the start of follow-up, with no movement of individuals between exposure groups during the follow-up, the groups are called fixed cohorts. • If no losses occur from a fixed cohort, the cohort satisfies the definition of a closed population and is often called a closed cohort 22
  • 23. 2. Obtaining data on Exposure • From Cohort Members : Personal interview, mailed questionnaire • Review of Records : Certain kinds of information like dose of radiation, kinds of surgery received can only be obtained from medical records. • Medical examination/ Special tests: In some cases information needs to be obtained from medical examination like in case of blood pressure, serum cholesterol, • Environmental Survey of location where cohort lives 23
  • 24. Information should be collected in a manner that allows classification of cohort according to • whether or not they have been exposed to suspected factor • According to level or degree of exposure • Demographic variables which might influence frequency of disease under investigation 24
  • 25. 3. Comparison Group Internal Comparison Group : Single Cohort enters the study and its members on the basis of information obtained , can be classified into several comparison according to degree of exposure Classification of exposure No. of Deaths Death rate ½ pack 24 95.2 ½ to 1 pack 84 107.82 1-2 pack 90 229.2 + 2 pack 97 264.2 Age Standardized death rate among 100000 men per year according to amount of cigarette smoking 25
  • 26. External Comparison Group: when information on degree of exposure is not available. if all workers at the factory had some degree of exposure, we would need to select a comparison group from another population, possibly another type of factory Comparison with general population can also be used as comparison group 26
  • 27. 4. Follow UP • The length of follow-up that is needed for some studies to reach a satisfactory end- point, when a large enough proportion of the participants have reached an outcome, may be many years or even decades. • At the start of study, method should be determined depending on the outcome of study to obtain data for assessing outcome. 27
  • 28. Procedure may be: • Periodic medical examination of each member of cohort • Reviewing physician and hospital records • Routine surveillance of death records • Mailed questionnaire, telephone calls and periodic home visits 28
  • 29. 5. Analysis Data analyzed in terms of • Incidence rate of outcome among exposed and non exposed • Estimation of risk 29
  • 30. Incidence rate Choice between cumulative incidence and Incidence Density is a crucial issue • Cumulative incidence: In cohort studies on acute diseases with short induction periods and a short time of follow-up, like outbreaks, the risk of disease can be estimated directly using the cumulative incidence, given a fixed cohort with fixed period of follow-up and a low fraction of drop-outs. • Incidence Density: In cohort studies on chronic diseases with their long follow-up periods, however, the use of the cumulative incidence is not appropriate because usually disease-free follow-up periods differ strongly among cohort members. In such case incidence density is apposite measure 30
  • 31. Death No death Incidence rate Total Exposed A B A/(A+B) A + B Unexpos ed C D C/(C+D) C + D Total A + C B + D A+B+C+ D Outcome* * Outcome : death/disease ANALYSIS OF COHORT STUDIES 31
  • 32. A = Exposed persons who later develop disease or die B = Exposed persons who do not develop diseases or die C = Unexposed persons who later develop disease or die D = Unexposed persons who do not develop diseases or die The total number of exposed persons = A + B The total number of unexposed persons = C + D Incidence of disease(or death) among exposed= A/A+B Incidence of disease(or death) among non-exposed= C/C+D 32
  • 33. Relative Risk (RR) • Estimates the magnitude of an association between exposure and disease • Indicates the likelihood of developing the disease in the exposed group relative to those who are not exposed • Ratio of risk of disease in exposed to the risk of disease in nonexposed Relative Risk RR = Risk in exposed(Incidence in exposed group) Risk in non exposed(Incidence in non exposed group) 33
  • 35. Children (<12 yrs) 1000 Family smoker 500 children Exposed Family non-smoker 500 children Not exposed Diseased 300 Not diseased 200 Diseased 120 Not diseased 380 OutcomeStart 35
  • 36. Rate: Incidence rate •Incidence of Resp. Infection among exposed children: 300 500 = 60% •Incidence of Resp. Infect. Among non exposed children: 120 500 = 24% 36
  • 37. Cohort Study (cont.)Relative Risk: Incidence rate among exposed Risk Ratio Incidence rate in non exposed. 60 24 = 2.5 Exposed individuals are 2.5 times more likely to develop disease than non exposed individuals. 37
  • 38. Difference Measures • Attributable risk – No. of cases among the exposed that could be eliminated if the exposure were removed = Incidence in exposed - Incidence in unexposed • Population Attributable Risk percentage: PAR expressed as a percentage of total risk in population 100x I I-I PAR% population unexposedpopulation = 38
  • 40. Yes No Incidence RD Yes 100 1900 2000 0.05 No 80 7920 8000 0.01 180 9820 10000 AR: Smoking and Lung cancer Smoking 0.04 Lung Cancer Attributable risk = Incidence in exposed - Incidence in unexposed =0.5-0.1 =0.4 40
  • 41. • Excess risk of disease in total population attributable to exposure • Reduction in risk which would be achieved if population entirely unexposed • Helps determining which exposures relevant to public health in community Population Attributable Risk (PAR) unexposedpopulation I-IPAR = 41
  • 42. Population Attributable Risk Risk Population Unexposed unexposedpopulation I-I Ipopln– Iunexposed 42
  • 43. Yes No Risk Yes 100 1900 2000 Incidence in exposed= 0.050 No 80 7920 8000 Incidence in unexposed=0.010 180 9820 10000 Incidence in population=0.018 PAR: Smoking 44%100x 0.018 0.010-0.018 PAR% == 0.0080.010-0.018PAR == Smoking Lung Cancer 43
  • 44. Conclusion: 44% of lung cancer in the population could be prevented if use of smoking were eliminated 44
  • 45. But calculations are not that simple in real Cohort studies 45
  • 46. British Doctors Study • In 1951, a prospective cohort study was set up among British doctors to investigate the relationship between smoking and mortality, particularly the association between smoking and lung cancer • In 1951, a questionnaire on smoking habits was sent to 49,913 male and 10,323 female doctors , 34,440 male doctors and 6194 female doctors gave sufficient information to classify their smoking status. • The causes of death of 10,072 male and 1094 female doctors who had died during this period were ascertained from death certificates. • The rate of death from lung cancer among smokers was compared to that among non-smokers. 46
  • 47. 47
  • 48. Since mortality depends on age and the distribution of subjects by age group is different between the smokers and non-smokers, the effect of age on mortality has to be adjusted for when making comparison on lung cancer mortality between these two groups. A commonly used method to adjust for the age is direct standardization 48
  • 49. It would not be rational to categorize individual smoking one cigarette per day and more than 25 cigarette in same category with equal emphasis So Its better we opt for stratification 49
  • 50. Again its not only the dose of exposure that determines the frequency of disease, there are some other factors like duration of exposure and age at initiation of exposure that can influence occurrence of disease. We need to make adjustment for that too 50
  • 51. The relative risk of lung cancer death increased with the level of smoking in both males and females. The relative risk in the men smoking 1–14 and 15– 24 cigarettes per day is much higher than in the women; in the group smoking 25 or more cigarettes per day, the relative risk in men is marginally less than that in women. Does this mean that the effect of low levels of smoking is higher among men than among women? 51
  • 52. The proportion of men inhaling smoke is higher than women in all three levels of smoking. Men seemed to have started to smoke at an earlier age than women. Since these features of smoking may modify the effect of smoking on lung cancer, their effects have to be adjusted for when comparing the association between smoking and lung cancer in men and women. 52
  • 53. …….. too complicated ???? But Problem does not end here…. 53
  • 54. What if, a subject is followed up from age 23 but has been exposed from age 19 on, he|she is exposed until age 27 followed by an unexposed 5 year period. He|she is again exposed until age 39 at which time his|her person-time at risk ceases either because of disease diagnosis or because of end of follow-up. 54
  • 55. For analyzing such data we use Poisson models and Cox Proportional Hazards Specialized software packages exist to perform these computations such as Stata (Version 7 or later and Epicure 55
  • 56. Advantage of Cohort Studies • Temporality can be established • Incidence ca be calculated. • Several possible outcome related to exposure can be studied simultaneously. • Provide direct estimate of risk. • Since comparison groups are formed before disease develops certain forms of bias can be minimized like misclassification bias. • Allows the conclusion of cause effect relationship 56
  • 57. Disadvantage of Cohort Studies • Large population is needed • Not suitable for rare diseases. • It is time consuming and expensive • Certain administrative problems like loss of staff, loss of funding and extensive record keeping are common. • Problem of attrition of initial cohort is common • Study itself may alter people’s behavior 57
  • 58. Ethics in Cohort Study • Classic example issues on research ethics is Tuskegee study on natural history of syphilis in which US Public health service recruited 399 poor black sharecroppers in Macon County as cohort. • Study was lasted from 1932 to 1972. • They were denied of treatment of syphilis although effective treatment was available. Government deceived by saying that they were being treated. 58
  • 59. Ethics in Cohort Study • On July 26, 1972, The New York Times described the study as “the longest non therapeutic experiment on human beings in medical history.” The disclosure of this study by the press was a major scandal in the United States. • Led to The Belmont Report: Ethical Principles and Guidelines for the Protection of Human Subjects in Research 59
  • 60. Ethics in Cohort Study • These problems can be encountered in cohort study designed to study natural history of disease. • What if treatment becomes available in the middle of research, should we continue research with treatment denial of abort research? • Should we communicate the research finding to individuals are controversial issues. 60
  • 61. Biases in cohort study Differential loss of follow up Differential follow-up between compared groups may be a major problem. Losses to follow-up, whether due to study withdrawals, unmeasured outcomes, or unknown reasons, are always a concern. This is particularly true when more outcome data is missing in one group than another, as there is no way to be certain that the factor being studied is not somehow related to this observation. 61
  • 62. Contamination Subjects initially unexposed to the risk factor of interest may become exposed at a later date. Such “ contamination ” tends to reduce the observed effect of the risk factor. 62
  • 63. Selection Bias Perhaps the largest threat to the internal validity of a cohort studies is selection bias, also called case-mix bias . Select participants into exposed and not exposed groups based on some characteristics that may affect the outcome Information bias− Collect different quality and extent of information from exposed and not exposed groups 63
  • 65. • Differential misclassification – Errors in measurement are one way only – Example: Measurement bias – instrumentation may be inaccurate, same cut off level of weight for male and female to determine malnourishment 65
  • 66. Misclassification Bias (cont.) 250100150 1005050Nonexposed 15050100Exposed TotalDisease-Disease + RR = a/(a+b)/c/(c+d) = 1.3 True Classification 250100150 905040Nonexposed 16050110Exposed TotalDisease -Disease + RR = a/(a+b)/c/(c+d) = 1.6 Differential misclassification - Overestimate exposure for 10 cases, inflate rates 66
  • 67. • Nondifferential (random) misclassification – errors in assignment of group happens in more than one direction – This will dilute the study findings - BIAS TOWARD THE NULL 67
  • 68. Misclassification Bias (cont.) Disease + Disease - Total Exposed 100 50 150 Nonexposed 50 50 100 150 100 250 RR = a/(a+b)/c/(c+d) = 1.3 True Classification Disease + Disease - Total Exposed 110 60 170 Nonexposed 40 40 80 150 100 250 RR = a/(a+b)/c/(c+d) = 1.3 Nondifferential misclassification - Overestimate exposure in 10 cases, 10 controls – bias towards null 68
  • 69. Control of Bias • Restriction • Stratification • Mathematical Modeling -Poisson regression model -Cox proportional hazard 69
  • 70. When Is a Cohort Study Warranted? • When the (alleged) exposure is known • When exposure is rare and incidence of disease among exposed is high (even if the exposure is rare, determined investigators will identify exposed individuals) • When the time between exposure and disease is relatively short • When adequate funding is available • When the investigator has a long life expectancy 70
  • 71. Reference • Park.k.,(2007), Park’s textbook of preventive and social medicine(19th edition) • Gordis.L.,(2008), Epidemiology.,(4th edition) • Framimgham Heart study retrived from www.framingham.com/heart/timeline.htm,on 29th Jan,2011. 71
  • 73. Classic example of Cohort study : Study on London Cholera Outbreak • The classical study on the London cholera epidemic of 1849 conducted by John Snow is an example of a cohort study on infectious diseases . • Two different water companies (the Lambeth and the Southwark & Vauxhall) supplied households within various regions of London 73
  • 74. Classic example of Cohort study : Study on London Cholera Outbreak • The companies differed in one important feature, the location of the water intake. The Lambeth had moved their water intake upstream from the sewage discharge point in 1849; whereas, the Southwark & Vauxhall continued to obtain water downstream of the sewage discharge point. • Dr. Snow classified households according to their exposure to the two water sources and showed a substantial difference in cholera mortality, 315 versus 37 cholera deaths per 10,000 households served by the Lambeth and Southwark & Vauxhall companies, respectively. 74

Editor's Notes

  1. By definition, such cases are not free of a specified disease, as in the case of a conventional cohort study (but are free of the ‘outcome of interest’).
  2. If the follow-up of fixed cohorts suffers from losses to follow-up incidence rates can still be measured directly and used to estimate average risks and incidence times. Accrue : periodic accumulated over time
  3. if all workers at the factory had some degree of exposure, we would need to select a comparison group from another population, possibly another type of factory, to ensure that the comparison group only differed in terms of their exposure and not in terms of other factors.
  4. In this case, outcome events are preferably described by rates, that represent the number of outcome events divided by the cumulated duration of event-free follow-up periods of all cohort members at risk.
  5. Relative Risk(RR) = Incidence of disease(or death) among exposed/Incidence of disease(or death) among non-exposed. Relative Risk(RR)= { A/(A+B)}/ { C/(C+D)}
  6. Defined as the ratio of the incidence of disease in the exposed group (expressed as Ie) divided by the corresponding incidence of disease in the non exposed group (Io)
  7. This is an important study and follow-up of participants is still under way. Results for 50 years of follow-up were published recently in the British Medical Journal (Doll et al. 2004).
  8. the estimation of level of exposure to tobacco by counting the number of cigarettes smoked per day may not be appropriate. For instance, the duration of smoking, inhalation practices and age when started to smoke might have been different Since mortality depends on age and the distribution of subjects by age group is different between the smokers and non-smokers, the effect of age on mortality has to be adjusted for when making comparison on lung cancer mortality between these two groups. A commonly used method to adjust for the age is direct standardization between the men and women. Unless the effects of these features of smoking are taken into account, one cannot conclude that low to moderate smoking has a higher effect in men than in women.
  9. In epidemiological cohort studies the standard model for analyzing such data is the Poisson model which is a statistical model of the disease rates. Basically the Poisson model assumes that the number of events di in each category i (combination of age category j and the kth combination of exposure variables) follows a Poisson distribution with parameter niλi. The standard (multiplicative) model would then assume that ln(λi) = αj + βk A comprehensive account of Poisson modeling is given by Breslow and Day (1987, Chap. 4). An alternative way of analysing event history data (another denomination of cohort data focussed on events), is by using Cox’ proportional hazard model. This model acknowledges that the categorisation of continuous data always implies a loss of information and therefore a loss in statistical power.Moreover, there is no need to explicitly estimate the effects of nuisance parameters if it can be avoided. The first step in proportional hazard model is the choice of one of the time variables considered. This basic time variable can either be age as was implicit at the beginning of this chapter, but in some settings, this variable can be the calendar time or even the time since the beginning of follow-up. Once this special time variable has been fixed, its effects are estimated nonparametrically. The key idea of Cox’s regression is that no information is lost when considering only the time points ti at which an event of interest occurs. At each such time point a “risk set” is set up including all members of the cohort contributing person-time (at risk and under observation) at this time point. If one wants to use a Cox model, the first step is thus to identify all risk sets. Then, one must obtain the value at
  10. Once investigators assemble the study cohorts, they are free to study more than one outcome, provided that the study subjects are free of each outcome of interest when the study begins. For the smoking and kidney transplant failure example, once cohorts of smokers and non-smokers are identified, investigators could also study whether smoking was associated with the development of kidney or bladder cancer, provided they exclude individuals who have evidence of these cancers at the beginning of the study. One of the largest cohort studies even conducted was the Nurses Health Study, which recruited 127,000 nurses between the ages of 30 and 55. The nurses completed questionnaires every 2 years that queried medical conditions, prescription and nonprescription medication use, social habits, dietary patterns, and physical activity. Creation of multiple cohort studies that evaluated risk factors for a wide range of diseases, including cancer, heart disease, and fractures. The British Doctors Study cohort was established in 1951 and followed for more than 50 years, although many of the original 40,701 participants are now dead. It has been of enormous value, particularly in relation to identifying the manifold health consequences of smoking. This is despite the fact that, compared with studies today, only limited exposure data were collected on a very short postal questionnaire mailed to the doctors at 10-year intervals since 1951 (Doll and Hill, 1964). The US Nurses’ Health Study started in 1976 with 121,964 female nurses aged 30–55, and 5 years of funding. Since then its focus has widened enormously from the oral contraceptive–breast cancer links for which it was first funded (Stampfer et al., 1988) to cover many exposures (including diet) and a multitude of outcomes. It has now accumulated more than 30 years of follow-up and is still going strong. It is very expensive to run, but the scientific and public health yield has been exceptional. The Nurses’ Health Study II began in 1989 with 117,000 nurses aged 25–42 (Rockhill et al., 1998) and recruitment has recently started for a Nurses’ Health Study III!
  11. It is now generally accepted that studies on humans should be carried out with informed consent. This principle, originally developed in relation to controlled clinical trials, has generally now been extended to observational epidemiology studies, including cohort studies. In the past, if a cohort was recruited that involved the subjects participation in providing data, their agreement to supply the data (e.g. respond to a questionnaire) was generally regarded as implied consent. However, now, in addition to providing information on questionnaires, for many cohorts, biological specimens (e.g. blood, buccal cells) are requested, and then it becomes mandatory that the respondent provide consent for the future use of such specimens for research purposes. However, at the time the specimens are provided, it is impossible to know the precise use the investigators may wish to apply to this material. An example relates to the fact that the majority of participants in the sub-cohorts of the European Prospective Investigation of Diet and Cancer (EPIC; Riboli and Kaaks 1997) provided blood specimens in the early 1990s; a few without signing a consent form, the majority did so. However, now that genetic studies are commonplace on such specimens, it has become apparent that some of the consent forms did not specifically mention genetic analyses as potential research usages. This has led to difficulties in obtaining approval for such sub-studies from human experimentation committees, some of which wanted new consent forms to be signed, specific to the genetically-associated sub-study planned. Obtaining new consent, however, will become increasingly difficult as time goes on, and a number of subjects with the endpoint of interest may have died. In the United States, potential restrictions upon studies such as these have caused difficulties. In Europe, especially Scandinavia, there has been a more relaxed view of the ethical acceptability of studies on stored specimens, many such collections having been originally made without a formal informed consent process, but for which studies conducted with full preservation of confidentiality have been deemed to be ethically acceptable.
  12. Intention to treat analysis : The conventional approach is to analyze the data in a intention-to treat fashion; that is, subjects are analyzed in the group to which they were originally assigned, regardless of what occurred after that point. Given that it reduces observed risk, however, some researchers choose to additionally analyze in a “ treatment-as-received ” manner. A number of statistical methods, including Cox proportional hazard modeling and Poisson regression, are suitable for this approach. In the latter technique, rather than allowing a single subject to remain in only one group for analysis, the amount of “ person time ” each subject represents within a study is considered. If the groups being compared consist of a given treatment versus no treatment or an alternate therapy, it is possible that some controls will start treatment or subjects may switch therapies.
  13. , such as using only one size blood pressure cuff to take measurements on both adults and children
  14. Previous reports from the Registrar General had drawn attention to the possibility that differences in water supply were associated with differences in cholera rates across sections of London.
  15. Previous reports from the Registrar General had drawn attention to the possibility that differences in water supply were associated with differences in cholera rates across sections of London.